Related Experiment Video
Updated: Jul 6, 2026

Manufacturing Abdominal Aorta Hydrogel Tissue-Mimicking Phantoms for Ultrasound Elastography Validation
Published on: September 19, 2018
The Impact of COVID-19 Infection on Abdominal Aortic Aneurysms: Mechanisms and Clinical Implications
Zenghan Cao1, Jianhang Gao1, Jianqiang Wu1,2,3
1Department of Vascular Surgery Peking Union Medical College Hospital Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
Insights
COVID-19 infection accelerates abdominal aortic aneurysms (AAAs) by disrupting the renin-angiotensin-aldosterone system (RAAS), immune response, and coagulation. Understanding these mechanisms is vital for future pandemic preparedness and treatment strategies.
Area of Science:
- Cardiovascular Research
- Infectious Diseases
- Pathophysiology
Background:
- COVID-19 poses significant health risks, impacting cardiovascular diseases like aortic aneurysms.
- Abdominal aortic aneurysms (AAAs) are life-threatening conditions exacerbated by various factors.
Purpose of the Study:
- To review foundational and clinical research on COVID-19's impact on abdominal aortic aneurysms (AAAs).
- To elucidate the mechanisms by which COVID-19 influences AAA progression and rupture risk.
Main Methods:
- Review of foundational research on RAAS, immune activation, and coagulation disorders.
- Summary of clinical studies, including AAA epidemiology during the pandemic and case reports.
Main Results:
- COVID-19 infection is linked to accelerated AAA progression and increased rupture risk.
- Mechanisms involve disruptions in the renin-angiotensin-aldosterone system (RAAS), immune dysregulation, and hypercoagulation.
Conclusions:
- COVID-19 influences AAA onset and progression via RAAS, inflammation, and coagulation.
- Comprehensive understanding is needed for preventative/therapeutic strategies against viral impacts on aortic diseases.
- Preparedness for future outbreaks involving cardiovascular complications is essential.
Abstract:
Background: The COVID-19 virus not only has significant pathogenicity but also influences the progression of many diseases, altering patient prognosis. Cardiovascular diseases, particularly aortic aneurysms, are among the most life-threatening conditions. Main Idea: COVID-19 infection is reported to accelerate the progression of abdominal aortic aneurysms (AAAs) and increase the risk of rupture; however, a comprehensive understanding of the underlying mechanisms remains elusive. This article primarily reviews the relevant foundational research, focusing on disruptions in the renin-angiotensin-aldosterone system (RAAS), immune system activation, and coagulation disorders. Furthermore, we summarize related clinical research, including the epidemiology of aortic aneurysms during the pandemic and specific case studies. Conclusion: COVID-19 infection can influence the onset and progression of aortic aneurysms by affecting the RAAS, triggering inflammation and immune dysregulation in the arterial wall, and inducing a hypercoagulation state. It is crucial to comprehensively understand the impact of pandemic viral infections on aortic diseases at the foundational and clinical levels, thereby identifying potential preventative or therapeutic approaches and preparing for potential future outbreaks.
More Related Videos
Related Concept Videos
Aortic Regurgitation I: Introduction
Aortic Regurgitation III: Medical Management
Aneurysm I: Introduction
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aneurysm III: Interprofessional Care
Aneurysm IV: Nursing Management

